James Kobie
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Cancer Vaccines | 4 | 2001 | 21 |
Why?
| Dendritic Cells | 4 | 2003 | 60 |
Why?
| 5'-Nucleotidase | 2 | 2005 | 7 |
Why?
| T-Lymphocytes, Regulatory | 2 | 2006 | 32 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 2005 | 113 |
Why?
| Adenosine | 2 | 2006 | 57 |
Why?
| Adenosine Monophosphate | 1 | 2006 | 14 |
Why?
| Growth Inhibitors | 1 | 2006 | 33 |
Why?
| Inflammation Mediators | 1 | 2006 | 56 |
Why?
| Transforming Growth Factor beta | 3 | 2001 | 99 |
Why?
| Th2 Cells | 4 | 2005 | 36 |
Why?
| Antigen Presentation | 1 | 2003 | 28 |
Why?
| Antibody-Producing Cells | 2 | 2008 | 20 |
Why?
| Th1 Cells | 3 | 2005 | 33 |
Why?
| Leukocytes, Mononuclear | 2 | 2008 | 67 |
Why?
| Antibodies, Monoclonal | 1 | 2003 | 241 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2006 | 64 |
Why?
| Glycoproteins | 2 | 2006 | 113 |
Why?
| Influenza Vaccines | 2 | 2008 | 70 |
Why?
| Cytokines | 4 | 2006 | 207 |
Why?
| Interferon-gamma | 4 | 2001 | 133 |
Why?
| Influenza, Human | 2 | 2008 | 94 |
Why?
| Mice, Inbred C57BL | 5 | 2003 | 318 |
Why?
| Mice | 11 | 2001 | 623 |
Why?
| T-Lymphocytes | 3 | 2001 | 182 |
Why?
| Mammary Neoplasms, Animal | 2 | 2001 | 13 |
Why?
| Flow Cytometry | 4 | 2001 | 216 |
Why?
| Mice, Inbred BALB C | 5 | 2001 | 176 |
Why?
| Basophils | 1 | 2010 | 13 |
Why?
| Mammary Neoplasms, Experimental | 2 | 2001 | 37 |
Why?
| Interleukin-3 | 1 | 2010 | 19 |
Why?
| Antigens, CD | 2 | 2008 | 128 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 2006 | 91 |
Why?
| Apyrase | 1 | 2009 | 12 |
Why?
| Clonal Anergy | 1 | 2009 | 20 |
Why?
| Lymphocytes | 2 | 2004 | 142 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2009 | 20 |
Why?
| Animals | 11 | 2001 | 1031 |
Why?
| Antibody Formation | 1 | 2010 | 89 |
Why?
| Blood Donors | 1 | 2008 | 19 |
Why?
| T-Lymphocyte Subsets | 2 | 2005 | 70 |
Why?
| Pattern Recognition, Automated | 1 | 2008 | 19 |
Why?
| Influenza A Virus, H3N2 Subtype | 1 | 2008 | 21 |
Why?
| Artificial Intelligence | 1 | 2008 | 16 |
Why?
| Microscopy, Fluorescence, Multiphoton | 1 | 2008 | 14 |
Why?
| Lymphoma, Follicular | 1 | 2009 | 27 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2008 | 27 |
Why?
| Trichuriasis | 1 | 2006 | 3 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2008 | 47 |
Why?
| Hybridomas | 1 | 2006 | 31 |
Why?
| Asthma | 1 | 2010 | 97 |
Why?
| Cells, Cultured | 3 | 2006 | 447 |
Why?
| Coculture Techniques | 1 | 2006 | 59 |
Why?
| Protein Processing, Post-Translational | 1 | 2007 | 78 |
Why?
| Cell Proliferation | 2 | 2006 | 227 |
Why?
| Antigens, Ly | 1 | 2005 | 7 |
Why?
| Pyrazoles | 1 | 2006 | 42 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2006 | 47 |
Why?
| Female | 9 | 2001 | 1643 |
Why?
| Gene Expression Profiling | 1 | 2008 | 138 |
Why?
| Sulfonamides | 1 | 2006 | 74 |
Why?
| Lymphocyte Activation | 2 | 2003 | 137 |
Why?
| Carcinoma, Lewis Lung | 1 | 2004 | 2 |
Why?
| Promoter Regions, Genetic | 1 | 2007 | 188 |
Why?
| Cell Differentiation | 2 | 2005 | 262 |
Why?
| DNA, Antisense | 1 | 2003 | 12 |
Why?
| Immunotherapy, Adoptive | 1 | 2003 | 10 |
Why?
| Vitamin E | 1 | 2004 | 38 |
Why?
| Cell Movement | 2 | 2001 | 163 |
Why?
| Antigens, CD40 | 1 | 2003 | 24 |
Why?
| Stem Cells | 1 | 2006 | 107 |
Why?
| Antigens, CD80 | 1 | 2001 | 19 |
Why?
| Lymph Nodes | 1 | 2003 | 106 |
Why?
| Lung Neoplasms | 1 | 2004 | 159 |
Why?
| Carcinoma | 1 | 2001 | 109 |
Why?
| Amino Acid Sequence | 1 | 2003 | 319 |
Why?
| Gene Therapy | 1 | 2001 | 89 |
Why?
| Molecular Sequence Data | 1 | 2003 | 404 |
Why?
| Young Adult | 2 | 2008 | 380 |
Why?
| Vaccination | 2 | 2004 | 92 |
Why?
| Humans | 7 | 2004 | 1856 |
Why?
| Signal Transduction | 1 | 2001 | 313 |
Why?
| Interleukin-3 Receptor alpha Subunit | 1 | 2010 | 5 |
Why?
| Pyrophosphatases | 1 | 2010 | 12 |
Why?
| Phosphoric Diester Hydrolases | 1 | 2010 | 29 |
Why?
| Hemagglutination Inhibition Tests | 1 | 2010 | 28 |
Why?
| Triazines | 1 | 2009 | 20 |
Why?
| Receptors, Purinergic P1 | 1 | 2009 | 19 |
Why?
| Cell Separation | 1 | 2010 | 110 |
Why?
| Triazoles | 1 | 2009 | 31 |
Why?
| Immunization | 1 | 2010 | 85 |
Why?
| Pyrimidines | 1 | 2009 | 49 |
Why?
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2008 | 17 |
Why?
| Neuroprotective Agents | 1 | 2009 | 60 |
Why?
| Cell Division | 2 | 2001 | 273 |
Why?
| Interleukin-2 | 1 | 2009 | 71 |
Why?
| Oligodeoxyribonucleotides | 1 | 2008 | 86 |
Why?
| Methylation | 1 | 2007 | 36 |
Why?
| Immunoglobulin G | 1 | 2010 | 191 |
Why?
| Lipopolysaccharides | 1 | 2008 | 98 |
Why?
| Adenosine Triphosphate | 1 | 2009 | 121 |
Why?
| Trichuris | 1 | 2006 | 2 |
Why?
| Cecum | 1 | 2006 | 11 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 224 |
Why?
| Intestinal Mucosa | 1 | 2006 | 56 |
Why?
| Receptors, CCR7 | 1 | 2005 | 3 |
Why?
| L-Selectin | 1 | 2005 | 11 |
Why?
| Immunity, Innate | 1 | 2006 | 60 |
Why?
| RNA, Messenger | 2 | 2001 | 394 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2006 | 53 |
Why?
| Immunotherapy | 1 | 2006 | 48 |
Why?
| Antibodies, Viral | 1 | 2008 | 104 |
Why?
| Histones | 1 | 2007 | 42 |
Why?
| Receptors, Chemokine | 1 | 2005 | 24 |
Why?
| Bone Marrow Cells | 1 | 2006 | 92 |
Why?
| Mice, Inbred C3H | 1 | 2005 | 86 |
Why?
| Administration, Oral | 1 | 2006 | 170 |
Why?
| Neovascularization, Pathologic | 1 | 2006 | 64 |
Why?
| Drug Administration Schedule | 1 | 2006 | 191 |
Why?
| Species Specificity | 1 | 2005 | 186 |
Why?
| Algorithms | 1 | 2008 | 226 |
Why?
| Adult | 2 | 2008 | 1317 |
Why?
| Cyclooxygenase 2 | 1 | 2006 | 77 |
Why?
| Tocopherols | 1 | 2004 | 9 |
Why?
| Mice, Knockout | 1 | 2007 | 265 |
Why?
| Polymerase Chain Reaction | 1 | 2006 | 279 |
Why?
| In Situ Nick-End Labeling | 1 | 2004 | 65 |
Why?
| Adjuvants, Immunologic | 1 | 2004 | 73 |
Why?
| Cell Line | 1 | 2006 | 375 |
Why?
| Gene Expression | 1 | 2005 | 291 |
Why?
| Oligonucleotides, Antisense | 1 | 2001 | 46 |
Why?
| Transgenes | 1 | 2001 | 56 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2001 | 12 |
Why?
| Genes, Dominant | 1 | 2001 | 68 |
Why?
| Male | 2 | 2008 | 1553 |
Why?
| Gene Expression Regulation | 1 | 2006 | 277 |
Why?
| Cross-Linking Reagents | 1 | 2001 | 38 |
Why?
| Transforming Growth Factor beta1 | 1 | 2001 | 43 |
Why?
| Neoplasm Metastasis | 1 | 2001 | 112 |
Why?
| Mice, SCID | 1 | 2001 | 61 |
Why?
| Time Factors | 1 | 2007 | 896 |
Why?
| Blotting, Northern | 1 | 2001 | 151 |
Why?
| Neoplasm Invasiveness | 1 | 2001 | 105 |
Why?
| Microscopy, Confocal | 1 | 2001 | 105 |
Why?
| Breast Neoplasms | 1 | 2006 | 185 |
Why?
| Cell Cycle | 1 | 2001 | 121 |
Why?
| Collagen | 1 | 2001 | 118 |
Why?
| Plasmids | 1 | 2001 | 122 |
Why?
| Survival Rate | 1 | 2001 | 250 |
Why?
| Blotting, Western | 1 | 2001 | 275 |
Why?
| Tumor Cells, Cultured | 1 | 2001 | 233 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 243 |
Why?
| Phenotype | 1 | 2001 | 303 |
Why?
| Apoptosis | 1 | 2004 | 265 |
Why?
| Dose-Response Relationship, Drug | 1 | 2001 | 431 |
Why?
| Transcription, Genetic | 1 | 2001 | 253 |
Why?
| Middle Aged | 1 | 2010 | 1161 |
Why?
| DNA-Binding Proteins | 1 | 2001 | 204 |
Why?
|
|
Kobie's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
